Equities

Grapefruit USA Inc

GPFT:PKC

Grapefruit USA Inc

Actions
  • Price (USD)0.0009
  • Today's Change0.000 / -18.18%
  • Shares traded100.00
  • 1 Year change-77.56%
  • Beta0.9982
Data delayed at least 15 minutes, as of Jul 30 2024 14:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Grapefruit USA, Inc. is a fully licensed cannabiotech company. The Company manufactures its product line and distribute it, along with other cannabis products, to all licensed cannabis product businesses. It owns an ethanol extraction facility in the City of Desert Hot Springs, California. It owns and operates a Type 6 Ethanol Extraction Plant which removes the essential cannabis compounds, such as THC Distillate, that the Company, and others use, to produce cannabis products. Grapefruit manufactures its Hourglass Time Release THC+CBD-Infused Topical Cream at its Coachillin' facility. Hourglass is the full spectrum THC+ Cannabinoid Topical delivery Cream that provides its users with a full body, synergistic entourage. Its Topical Cream is designed to deliver the full effects of THC combined with a range of cannabinoids for a user's overall health, wellness, and well-being. In addition, its extraction lab produces distillate or Honey Oil from cannabis trim sourced by Grapefruit.

  • Revenue in USD (TTM)34.85k
  • Net income in USD-4.37m
  • Incorporated2017
  • Employees9.00
  • Location
    Grapefruit USA Inc10866 Wilshire Blvd.LOS ANGELES 90024United StatesUSA
  • Phone+1 (310) 205-1382
  • Fax+1 (818) 260-0445
  • Websitehttp://imaging3.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
ITonis Inc0.00-1.17m685.53k-----------0.0012-0.00120.00-0.00040.00-------187.63---1,169.36-------------0.8999---------506.86------
Neutra Corp17.40k-474.98k875.37k--------50.31-0.0002-0.00020.00001-0.00030.27860.4126-----758.75-682.94----46.15---2,723.22-2,758.850.0009-14.06-----26.09--22.28------
Agentix Corp0.00-1.01m1.05m-----------0.0253-0.02530.00-0.0710.00-------907.08-----------------96.41----------------
Scorpius Holdings Inc9.74m-32.20m1.13m82.00--0.0145--0.1164-244.34-280.0573.26158.750.1372--26.56118,815.70-47.81-39.37-58.20-43.1868.56---348.43-1,068.210.2641-198.180.3179--1,789.583.841.96--27.32--
InVitro International716.89k6.22k1.16m16.00145.711.59--1.620.00040.00040.04020.03211.15------0.9957.891.098.83----0.86765.90---------5.111.33-87.77-16.14----
Grapefruit USA Inc34.85k-4.37m1.22m9.00------34.93-0.008-0.0080.00006-0.01010.01211.310.22593,872.22-151.85-268.93-----1,304.65-10.09-12,531.68-408.870.0388-1.50-----83.9677.87-35.68------
Nexien Biopharma Inc0.00-246.18k1.32m0.00---------0.0038-0.00380.00-0.00480.00-------679.40-860.53---1,653.53-----------1.77--------42.22------
PainReform Ltd0.00-12.54m1.37m6.00--0.3954-----7.77-7.770.000.99880.00----0.00-158.88-55.47-222.89-68.20------------0.00-------6.28------
Panacea Life Sciences Holdings Inc2.76m-7.67m1.56m40.00------0.5631-0.4554-0.45540.164-0.52550.15371.6210.1369,098.25-42.65-69.04---225.03-139.49-181.62-277.51-505.410.0285-2.124.79--46.59--12.33------
SOHM Inc-100.00bn-100.00bn1.60m--------------------------------------------------------------
Mallinckrodt PLC1.91bn-1.49bn1.60m2.80k------0.0008-161.65-161.6389.6355.440.40621.574.94681,821.40-31.61-12.49-36.10-15.8526.2235.68-77.83-44.381.63-0.34560.6164---2.53-10.31-83.00------
Stemcell Holdings Inc9.98m3.10m1.64m------0.50080.16450.000080.000080.00030.00021.12--5.20--34.90--68.19--77.19--31.04------0.00--85.10--71.82------
Link Reservations Inc0.00-480.90k1.69m0.00---------46.51-46.510.00-13.990.00-------246.84-----------------2.43---------22.69------
Aoxing Pharmaceutical Company Inc30.11m-1.46m1.71m339.00--0.0199--0.0567-0.0192-0.01920.39510.25070.4962.322.56---2.41-14.54-7.06-35.4576.1968.51-4.85-37.690.73680.33870.6052--26.8837.20-62.49---38.80--
Data as of Jul 30 2024. Currency figures normalised to Grapefruit USA Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.